Testing a new home hemodialysis machine
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new home hemodialysis machine called the Moda-flx System. If you are on stable dialysis and have a care partner, you and your partner will learn how to use the machine at home, and the trial will see if it can safely and effectively replace your regular dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old, and your care partner must be at least 18.
- Your current dialysis must be working well (doing a good job of cleaning your blood).
- You must have a working access point for dialysis (like a fistula, graft, or tunneled catheter) that can handle a fast enough blood flow.
- You and your care partner need to complete a training program and pass a skills test before the trial starts.
- You cannot have had serious low blood pressure during recent dialysis sessions that needed treatment, or a recent heart event.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting dialysis at twice a week, instead of the usual three times, is safe and effective for people who still have some kidney function. If the kidneys still make urine and clear waste, being on dialysis less often may maintain that function longer.
This study tests a new dialysis machine called the Solv Multi-Pass System in a dialysis center. It looks at whether the machine works safely and effectively for people with end-stage kidney disease who need regular hemodialysis.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
Hear when a new End Stage Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.